Stay updated on MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Recruitment status updated to not currently enrolling participants. New navigation sections—How to Read a Study Record, Common Questions, and How to Join a Study—were added, and the Intervention/Treatment heading formatting was updated along with the revision label from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T11:43:52.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page’s revision number was updated from v3.5.4 to v3.5.5, signaling a backend release with no impact on the study data or user-facing information.
    Difference
    0.1%
    Check dated 2026-06-05T08:29:53.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    The page revision label changes from v3.5.3 to v3.5.4, indicating a new version of the page rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-05-14T23:08:08.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page’s revision/version label has been updated from v3.5.2 to v3.5.3, reflecting a deployed update to the page. No changes to the study details or other substantive content are indicated.
    Difference
    0.1%
    Check dated 2026-04-30T15:55:22.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The study record history shows updated date entries (newly reflected 2026 dates) and removed prior 2025 date entries, indicating the page was refreshed with new record/update information.
    Difference
    0.3%
    Check dated 2026-04-23T14:58:36.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T11:08:55.000Z thumbnail image

Stay in the know with updates to MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page.